NCT07234331 (E-FLUENT) is a clinical trial in Antimicrobial Resistance, sponsored by Nantes University Hospital.

Who is sponsoring NCT07234331?

NCT07234331 is sponsored by Nantes University Hospital.

What condition does NCT07234331 study?

NCT07234331 studies Antimicrobial Resistance.

Is NCT07234331 still recruiting?

NCT07234331 is currently recruiting now. Last updated 16 April 2026.

Last reviewed 2026-04-16 · How we verify

NCT07234331: E-FLUENT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.

Recruiting now Last updated 16 April 2026

What this trial tests

trial in Antimicrobial Resistance in 1,600 participants. Currently enrolling.

Timeline

16 March 2026

Primary endpoint
31 March 2027

30 June 2027

Quick facts

Lead sponsor	Nantes University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,600
Start date	16 March 2026
Primary completion	31 March 2027
Estimated completion	30 June 2027
Sites	2 locations across France

Conditions studied

Antimicrobial Resistance — all drugs for Antimicrobial Resistance →

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Antimicrobial Resistance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to model the relationship between the prevalence of ESBL-E and CPE carriage among nursing home residents and their respective concentrations in wastewater discharged from the facility.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Antimicrobial Resistance

Currently open trials in the same condition.

NCT06436690 — Optimizing Antibiotics Prescription · NA · active not recruiting
NCT06566898 — Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients · recruiting
NCT06358872 — Azithromycin for Child Survival in Niger II · Phase 4 · recruiting
NCT05296837 — Ocular Rosacea Biome Study · Phase 4 · active not recruiting

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07234331 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 16 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07234331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing